Kevin Winthrop - Concepedia

Author

Kevin Winthrop

Oregon Health & Science University ORCID

Also Known As

Aridaman Pandit, K L Winthrop, K Winthrop, K. L. Winthrop, K. Winthrop, K.L. Winthrop, KEVIN L. WINTHROP, KEVIN WINTHROP, Kevin L Winthrop, Kevin L. Winthrop

803

Publications

48.2K

Citations

102

H-Index

119

Concepts

All Affiliations

Oregon Health & Science University University of Alabama at Birmingham Charité - Universitätsmedizin Berlin University of Pennsylvania University of Colorado Denver

About

Kevin Winthrop is an author at Oregon Health & Science University specializing in medicine, clinical microbiology, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	54	5.8K
2	Public Health	12	12	855
3	Health Sciences	7	7	629
4	Allergy	3	3	89
5	Athletic Training	1	1	283

Kevin Winthrop

215

Publications

26K

Citations

H-Index

Page 1

	Year	Citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Annals of the Rheumatic Diseases	2013	1.8K
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Annals of the Rheumatic Diseases	2022	1.6K
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) Maxime Dougados, Martin Soubrier, Anna Antunez, Annals of the Rheumatic Diseases	2013	841
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study Wouter Hoefsloot, Jakko van Ingen, Claire Andréjak, European Respiratory Journal	2013	835
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, European Respiratory Journal	2020	808
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Clinical Infectious Diseases Pulmonary TuberculosisPulmonary CareMycobacterium AbscessusAdvanced Lung DiseasePathology	2020	770
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Clinical Infectious Diseases Pulmonary TuberculosisPulmonary CareMycobacterium AbscessusAdvanced Lung DiseasePathology	2020	739
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010 Daniel E. Fürst, Edward Keystone, Jürgen Braun, Annals of the Rheumatic Diseases	2011	691
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman, Thorax Pulmonary TuberculosisEpidemiologyPreventive MedicineAdvanced Lung DiseaseTuberculosis Prevention	2015	459
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman, Thorax Pulmonary TuberculosisEpidemiologyConsensus RecommendationsPulmonary PathologyAdvanced Lung Disease	2015	458

Page 1